Xilio Development Inc (XLO) is a biotechnology company listed on NASDAQ.
Latest reported XLO revenue for 2026-06-30 was $31.3M. Net income was -$15.9M. XLO currently screens at market cap $55.3M.
Use this XLO page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the XLO quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the XLO SEC filings page. Lician reads the product cache first so this HTML stays unique to Xilio Development Inc even when a live quote feed is slow.
Latest cached year on this hub. Full XLO income, balance, and cash tables.